Alvita Pharma Private Limited, a active private limited company, was established on 23 January 2010 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2010PTC059305. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.00 Cr.
It upholds a compliant status. Employing 55 professional, Its leadership includes Manoj Ramaniklal Vora (Director), Surendra Kumar Lohia (Director), Sajan Parmeswaran Unnithan (Director). Past directors included Manoj Ramaniklal Vora, Surendra Kumar Lohia, Jaynesh Ratilal Patel. It holds ₹6.00 Cr open charges and ₹59.65 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B 203, Gopal Palace, Near Nehru Nagar Circle, Satellite Road, Ambavadi, Ahmedabad, Gujarat, 380015.
U24230GJ2010PTC059305
059305
23 January 2010
₹10.00 Cr
₹9.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Alvita Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manoj Ramaniklal Vora | Director | 14 Jul 2010 | Current |
| Surendra Kumar Lohia | Director | 02 Feb 2015 | Current |
| Sajan Parmeswaran Unnithan | Director | 16 Sep 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Jul 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 31 Mar 2011 | Past |
| Pramod Abcsdd | Additional Director | 18 Jul 2011 | Past |
| Pramod Abcsdd | Director | 31 Mar 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Alvita Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.91% decrease. The company also saw a slight improvement in profitability, with a 6.82% increase in profit. The company's net worth Soared by an impressive increase of 25.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Alvita Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹60,000,000.00
₹596,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2013 | Others | ₹6.00 Cr | Open |
| 10 Dec 2020 | Hdfc Bank Limited | ₹30.51 Cr | Satisfied |
| 26 Jul 2017 | Indian Bank | ₹27.70 Cr | Satisfied |
| 23 Jan 2015 | Kotak Mahindra Bank Limited | ₹1.44 Cr | Satisfied |
Explore comprehensive loan charge details -
Alvita Pharma has a workforce of 55 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alvita Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alvita Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Alvita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Alvita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge with Others of Rs. 6.00 Cr registered on 03 Jan 2013 with Charge ID 10405597 was modified on 30 Mar 2024. was documented.
The activity A charge registered on 10 Dec 2020 via Charge ID 100414441 with Hdfc Bank Limited was fully satisfied on 23 May 2022. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 30.51 Cr with Charge ID 100414441 was registered on 10 Dec 2020. was recorded as a recent event.
Progress on A charge registered on 26 Jul 2017 via Charge ID 100121805 with Indian Bank was fully satisfied on 17 Jul 2020. was documented.
The CIN of Alvita Pharma Private Limited is U24230GJ2010PTC059305.
Alvita Pharma Private Limited is headquartered at B 203, Gopal Palace, Near Nehru Nagar Circle, Satellite Road, Ambavadi, Ahmedabad, Gujarat, 380015.
Alvita Pharma Private Limited was incorporated on 23 January 2010.
The current directors of Alvita Pharma Private Limited are
The primary industry of Alvita Pharma Private Limited is Manufacturing.
Alvita Pharma Private Limited is unlisted.
The authorized capital of Alvita Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.00 Cr.
The compliance status of Alvita Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX